VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
WRB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
WRBW. R. Berkley Corporation
$77.57$28.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWRBFinancials

W. R. Berkley Corporation (WRB) Income Statement

30Y historyFree accessUpdated daily

Quarterly combined ratios have mostly held between 80% and 86%, with net income ranging from $365.6M to $576.1M over the last ten quarters, though revenue growth and loss ratios have been volatile, moving from 28.7% to 78.6% in the most recent two quarters.

Income StatementBalance SheetCash FlowRatios

WRB Income Statement

Annual statement

WRB Income Statement

W. R. Berkley Corporation (WRB) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue17.98B14.71B13.64B12.14B11.17B9.46B8.1B7.9B7.69B8.01B7.65B7.21B7.54B6.41B5.82B4.91B4.51B4.43B4.71B5.59B5.39B5B4.51B3.63B2.57B1.94B1.78B1.67B1.58B1.4B1.23B
Revenue Growth %22.72%7.82%12.32%8.74%18.1%16.75%2.49%2.74%-3.99%4.66%6.21%-4.41%17.64%10.05%18.63%8.91%1.72%-5.9%-15.74%3.59%7.96%10.74%24.3%41.46%32.15%9.01%6.43%5.76%13.01%14.29%19.89%
Medical Costs & Claims9.79B11.79B10.52B9.42B8.73B7.43B6.75B6.42B6.31B6.36B6.21B5.92B5.49B4.28B3.95B3.52B3.09B2.34B2.69B3.11B3.15B3.02B2.76B2.96B1.46B1.38B1.09B1.09B914.76M734.42M669.16M
Medical Cost Ratio %54.45%80.19%77.11%77.56%78.17%78.61%83.36%81.29%82.04%79.43%81.17%82.1%72.82%66.74%67.85%71.68%68.57%52.73%57.1%55.61%58.46%60.52%61.27%81.42%57.05%71.09%61.44%64.88%57.8%52.45%54.62%
Gross Profit8.19B2.91B3.12B2.72B2.44B2.02B1.35B1.48B1.38B1.65B1.44B1.29B2.05B2.13B1.87B1.39B1.42B2.09B2.02B2.48B2.24B1.97B1.75B674.58M1.1B561.3M686.88M587.84M667.75M665.88M556.01M
Gross Margin %45.55%19.81%22.89%22.44%21.83%21.39%16.64%18.71%17.96%20.57%18.83%17.9%27.18%33.26%32.15%28.32%31.43%47.27%42.9%44.39%41.54%39.48%38.73%18.58%42.95%28.91%38.56%35.12%42.2%47.55%45.38%
Gross Profit Growth %--6.66%14.58%11.75%20.53%50.08%-8.82%7.01%-16.18%14.34%11.74%-37.05%-3.88%13.85%34.67%-1.85%-32.36%3.68%-18.56%10.69%13.62%12.87%159.06%-38.79%96.35%-18.28%16.85%-11.97%0.28%19.76%23.3%
Operating Expenses5.82B579.43M857.12M969.99M718.33M739.87M642.96M625.23M569.26M875.24M544.93M557.93M1.1B1.43B1.17B877.39M817.76M1.71B1.69B1.39B1.25B1.2B1.11B185.28M842.68M712.69M646.02M667.09M604.97M-685.52M440.96M
OpEx / Revenue %32.36%3.94%6.28%7.99%6.43%7.82%7.94%7.91%7.4%10.93%7.12%7.74%14.55%22.36%20.1%17.87%18.14%38.64%35.97%24.84%23.22%24.06%24.58%5.1%32.84%36.7%36.27%39.86%38.23%-48.96%35.99%
Depreciation & Amortization-37.6M-32.82M-170.64M-20.86M55.87M129.68M135.06M113.39M131.11M112.96M86.05M85.14M88.84M103.09M103.42M88.01M82.87M78.88M83.95M73.7M65.67M63.05M54.83M20.32M17.94M17.49M21.7M23.6M22.66M11.9M8.59M
Combined Ratio %86.81%84.13%83.4%85.55%84.6%86.43%91.3%89.21%89.44%90.35%88.29%89.84%87.37%89.09%87.95%89.55%86.71%91.37%93.07%80.45%81.67%84.58%85.85%86.52%89.89%107.8%97.71%104.73%96.03%3.49%90.61%
Operating Income2.37B2.33B2.26B1.75B1.72B1.28B704.8M852.92M812.09M772.77M896.44M732.03M952.2M698.89M701.93M513.09M598.91M382.23M326.32M1.09B988.64M770.54M638.51M489.3M259.43M-151.39M40.85M-79.25M62.78M1.35B115.05M
Operating Margin %13.19%15.87%16.6%14.45%15.4%13.57%8.7%10.79%10.56%9.65%11.71%10.16%12.63%10.91%12.05%10.45%13.29%8.63%6.93%19.55%18.33%15.42%14.15%13.48%10.11%-7.8%2.29%-4.73%3.97%96.51%9.39%
Operating Income Growth %-3.08%29.07%2.02%34.05%82.02%-17.37%5.03%5.09%-13.8%22.46%-23.12%36.24%-0.43%36.81%-14.33%56.69%17.13%-70.13%10.49%28.31%20.68%30.49%88.61%271.36%-470.6%151.55%-226.23%-95.35%1074.63%39.04%
EBITDA2.36B2.3B2.09B1.73B1.78B1.41B839.87M966.31M943.2M885.73M982.49M817.17M1.04B801.98M805.35M601.1M681.78M461.11M410.27M1.17B1.05B833.59M693.34M509.63M277.38M-133.9M62.55M-55.65M85.44M1.36B123.64M
EBITDA Margin %13.13%15.65%15.35%14.28%15.9%14.94%10.37%12.23%12.26%11.06%12.84%11.34%13.81%12.51%13.83%12.24%15.13%10.41%8.71%20.87%19.54%16.68%15.37%14.04%10.81%-6.9%3.51%-3.33%5.4%97.36%10.09%
Interest Expense126.68M126.89M126.91M127.46M130.37M147.18M150.54M153.41M157.19M147.3M140.9M130.95M128.17M123.18M126.3M112.51M106.97M87.99M84.62M89M92.52M85.93M66.42M54.73M45.48M45.72M47.6M50.8M48.82M48.87M31.96M
Non-Operating Income-90.12M-70.74M-126.91M-127.46M-130.37M-147.18M-150.54M-153.41M-157.19M-147.3M-140.9M-130.95M-128.17M-123.18M-126.3M-112.51M-106.97M-87.99M-84.62M-89M-92.52M-85.93M-66.42M-54.73M-45.48M-45.72M-47.6M-50.8M-48.82M1.3B-31.96M
Pretax Income2.34B2.28B2.26B1.75B1.72B1.28B704.8M852.92M812.09M772.77M896.44M732.03M952.2M698.89M701.93M513.09M598.91M382.23M326.32M1.09B988.64M770.54M638.51M489.3M259.43M-151.39M40.85M-79.25M62.78M129.7M115.05M
Pretax Margin %13%15.51%16.6%14.45%15.4%13.57%8.7%10.79%10.56%9.65%11.71%10.16%12.63%10.91%12.05%10.45%13.29%8.63%6.93%19.55%18.33%15.42%14.15%13.48%10.11%-7.8%2.29%-4.73%3.97%9.26%9.39%
Income Tax466.63M495.77M509.92M370.56M334.73M251.89M171.82M168.94M163.03M219.43M292.95M227.92M302.59M193.59M191.28M121.94M152.23M73.15M44.92M323.07M286.4M222.52M196.24M150.63M84.14M-56.66M2.45M-45.77M5.46M30.7M25.1M
Effective Tax Rate %19.96%21.74%22.52%21.12%19.46%19.63%24.38%19.81%20.08%28.4%32.68%31.14%31.78%27.7%27.25%23.77%25.42%19.14%13.77%29.57%28.97%28.88%30.73%30.78%32.43%37.43%6%57.75%8.7%23.67%21.82%
Net Income1.86B1.78B1.76B1.38B1.38B1.02B530.67M681.94M640.75M549.09M601.92M503.69M648.88M499.93M510.59M391.21M446.4M309.06M281.14M766.24M699.52M544.89M438.11M337.22M175.04M-91.55M34.08M-36.6M58.76M99M90.26M
Net Margin %10.36%12.1%12.88%11.38%12.37%10.81%6.55%8.63%8.33%6.85%7.86%6.99%8.61%7.8%8.77%7.97%9.9%6.97%5.97%13.71%12.97%10.9%9.71%9.29%6.82%-4.71%1.91%-2.19%3.71%7.07%7.37%
Net Income Growth %-2.26%1.33%27.13%0.02%35.07%92.68%-22.18%6.43%16.69%-8.78%19.5%-22.38%29.8%-2.09%30.52%-12.36%44.44%9.93%-63.31%9.54%28.38%24.37%29.92%92.65%291.21%-368.65%193.1%-162.29%-40.65%9.68%48.26%
EPS (Diluted)4.764.454.363.373.292.441.251.561.481.261.391.151.441.051.581.201.280.830.721.731.541.210.980.760.44-0.270.12-0.120.140.270.22
EPS Growth %-0.63%2.06%29.38%2.43%34.84%95.2%-19.87%5.41%17.46%-9.35%20.87%-20.14%37.14%-33.54%31.67%-6.25%54.22%15.28%-58.38%12.34%27.27%23.47%28.95%72.73%262.96%-325%200%-185.71%-48.15%22.73%29.41%
EPS (Basic)-4.484.393.403.332.461.261.591.481.301.451.201.501.091.651.261.330.860.751.801.621.271.030.800.45-0.270.12-0.120.140.270.22
Diluted Shares Outstanding391.34M399.13M403.22M409.95M419.19M419.62M424.72M435.42M432.89M435.44M433.87M439.39M451.08M475.01M322.46M327.76M348.93M374.79M390.27M442.57M454.89M450.74M446.03M441.13M400.98M333.42M296.96M295.2M330.94M343.29M339.73M

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Social inflation reserve adequacy risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Underwriting Discipline Holds Despite Volatility

Based on reported quarterly figures, WRB's combined ratio ranged from 80.1% to 91.6% over the last ten quarters, with most readings staying below 86%, suggesting underwriting profitability has been broadly maintained across the period.

The combined ratio sitting below 100% in every reported quarter indicates underwriting profit rather than reliance on investment income to close a gap. The quarterly spread, particularly the elevated 91.6% reading in 2026Q2 against a 78.6% loss ratio in 2026Q3, appears driven by catastrophe timing and expense ratio swings rather than a clear structural deterioration. Investors should monitor whether the loss ratio drift upward in later quarters reflects genuine casualty cost pressure.

Premium Growth Uneven Across Quarters

As reported in the quarterly income statement, WRB's revenue growth swung from 86.1% in 2026Q2 to negative 0.6% in 2026Q3, indicating that top-line expansion is lumpy and not yet showing a consistent trend.

The 86.1% spike appears to reflect a period-specific item rather than a sustained rate or exposure expansion, given the surrounding quarters grew in the low-to-mid single digits. The sharp reversal to flat revenue in the most recent quarter may indicate a slowing in new business or tighter underwriting appetite, though the data alone does not confirm the cause. Investors should treat the 1Y peer growth comparison as more reliable than any single quarter.

Earnings Quality Depends on Reserve Development

Based on reported figures, quarterly net income fell from $576.1M in 2024Q4 to $449.5M in 2025Q4 while the combined ratio stayed in the 80s, suggesting earnings movements may partly reflect reserve and investment timing.

The EPS decline of 21.5% in 2025Q4 alongside a stable combined ratio is a pattern that warrants further investigation into prior-year reserve development, since reserve releases can inflate current earnings. Data on favorable or adverse development is not provided here, so this cannot be confirmed. Analysts should review the reserve roll-forward to determine whether current margins are being supported by prior-year estimates.

Social Inflation Threatens Reported Margins

The reported 15.9% operating margin and 19.6% ROE leave limited room for reserve volatility, and escalating litigation costs in long-tail casualty lines could pressure these figures if prior estimates require upward revision.

The strongest challenge to WRB's earnings is that casualty reserves established during lower-inflation assumptions may prove insufficient, which would convert today's underwriting profit into future reserve strengthening charges. Peer net margins from RLI at 21.4% and WTM at 40.9% suggest WRB's profitability is not at the top of the group, so the margin cushion is not exceptional. Investors should monitor reserve adequacy disclosures closely.

Investment Income Supports Total Earnings

Based on reported figures, WRB's net investment income appears to be a meaningful supplement to underwriting results, though the supplied data does not disclose the investment income line or yield directly.

With a combined ratio that is consistently below 100%, investment income is not structurally required to achieve profitability, but it likely lifts total pre-tax returns in a higher-rate environment. The absence of a disclosed investment income figure in the supplied data means the magnitude of this contribution cannot be quantified here. Investors should examine the portfolio yield trend against liability costs to assess sustainability.

WRB — Frequently Asked Questions

Quick answers to the most common questions about buying WRB stock.

What was W. R. Berkley Corporation's (WRB) revenue in 2025?

For fiscal year 2025, W. R. Berkley Corporation (WRB) reported total revenue of $14.71B. This represents a 1100.3% increase compared to $1.23B in 1996.

Is W. R. Berkley Corporation (WRB) profitable?

W. R. Berkley Corporation (WRB) is profitable, generating $1.78B in net income for the fiscal year ending 2025 with a net profit margin of 12.1%.

What is W. R. Berkley Corporation's operating profit margin?

W. R. Berkley Corporation (WRB) reported an operating income of $2.33B, resulting in an operating profit margin of 15.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is W. R. Berkley Corporation's gross profit and gross margin?

W. R. Berkley Corporation (WRB) generated $2.91B in gross profit for the year, representing a gross profit margin of 19.8%. This demonstrates the company's core pricing power and production efficiency.